Richard C. Woodman
Director/Miembro de la Junta en H3 Biomedicine, Inc. .
Cargos activos de Richard C. Woodman
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
H3 Biomedicine, Inc.
 H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa. | Director/Miembro de la Junta | 11/01/2022 | - |
Historial de carrera de Richard C. Woodman
Antiguos cargos conocidos de Richard C. Woodman.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| TRAWS PHARMA, INC. | Director Técnico/Científico/I+D | 07/11/2018 | 15/01/2021 |
Novartis, Inc.
 Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco. | Director Técnico/Científico/I+D | 01/01/2006 | 01/03/2018 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | 01/01/2002 | 01/01/2006 |
| EISAI CO., LTD. | Corporate Officer/Principal | - | - |
| University of Calgary | Corporate Officer/Principal | 01/01/1990 | - |
Formación de Richard C. Woodman.
| University of Calgary | Doctorate Degree |
| University of British Columbia | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
| Canadá | 3 |
| Japón | 2 |
Operativa
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
Sectorial
| Health Technology | 6 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| TRAWS PHARMA, INC. | Health Technology |
| JOHNSON & JOHNSON | Health Technology |
| EISAI CO., LTD. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco. | Health Technology |
H3 Biomedicine, Inc.
H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa. | Health Technology |
- Bolsa de valores
- Insiders
- Richard C. Woodman
- Experiencia
